Cost-Effectiveness Analysis (CEA) of Linezolid Versus Vancomycin in the Treatment of Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA-NP) Based on a Phase IV Clinical Trial- Results from Four Major Cities in ...
Abstract
Authors
Y. Wan X. Wang B. Wu H. Kang Q. Li Y. Chen J.Z. Li S. Liu X. Gao